Medicare Enrolled
Dr. Mustafa Dohadwala, M.D.
Cardiovascular Disease · Dallas, TX
Practice pattern: Electrophysiology & Remote— Practice combining electrophysiology and remote services
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dohadwala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dohadwala? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dohadwala
Dr. Mustafa Dohadwala is a cardiovascular disease in Dallas, TX, with 18 years in practice. Based on federal Medicare data, Dr. Dohadwala performed 6,192 Medicare services across 3,843 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dohadwala received a total of $70,263 from 32 pharmaceutical and/or device companies across 388 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dohadwala is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 11% volume in TX$ $70,263 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,192
Medicare services
Top 11% in TX for cardiovascular disease
3,843
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~344 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote pacemaker/defibrillator monitoring, 90 days | 1,048 | $16 | $84 |
| Remote pacemaker monitoring, 90 days | 808 | $21 | $109 |
| Blood draw (venipuncture) | 556 | $8 | $17 |
| Electrocardiogram (EKG), 12-lead | 418 | $10 | $51 |
| Programming of dual lead pacemaker system | 408 | $56 | $299 |
| Office visit, established patient (30-39 min) | 372 | $89 | $238 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 268 | $26 | $181 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 225 | $18 | $95 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 211 | $19 | $95 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 143 | $24 | $75 |
| Office visit, established patient, complex (40-54 min) | 132 | $128 | $335 |
| Hospital follow-up visit, moderate complexity | 126 | $61 | $186 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 121 | $19 | $98 |
| Programming of multiple lead implantable defibrillator system | 120 | $75 | $397 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 105 | $17 | $98 |
| Programming of multiple lead pacemaker system | 97 | $61 | $317 |
| Evaluation of cardiac rhythm monitor system | 88 | $36 | $187 |
| Initial hospital admission, high complexity | 80 | $129 | $517 |
| New patient office visit (45-59 min) | 70 | $122 | $310 |
| Programming of dual lead implantable defibrillator system | 66 | $71 | $366 |
| New patient office visit, complex (60-74 min) | 62 | $152 | $409 |
| Repair of left upper heart chamber with implant with review by radiologist | 61 | $581 | $2,979 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 57 | $365 | $1,984 |
| Initial hospital admission, moderate complexity | 56 | $100 | $352 |
| Heart rhythm recording of continous external ekg over 8-15 days | 55 | $9 | $96 |
| New patient office visit (30-44 min) | 50 | $82 | $207 |
| Programming of single lead pacemaker system | 45 | $49 | $253 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 41 | $346 | $1,774 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 40 | $9 | $96 |
| Evaluation of implantable heart and blood vessel monitoring system | 40 | $34 | $203 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 36 | $225 | $1,089 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 31 | $686 | $3,987 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 28 | $223 | $1,090 |
| Programming of cardiac rhythm monitor system | 24 | $46 | $228 |
| Insertion of implantable defibrillator system | 23 | $681 | $3,503 |
| Insertion of heart rhythm monitor under skin | 20 | $54 | $333 |
| Destruction of heart conduction tissue to create heart block | 17 | $436 | $2,065 |
| External shock to heart to regulate heart beat | 15 | $81 | $707 |
| Office visit, established patient (20-29 min) | 15 | $63 | $168 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 14 | $124 | $1,094 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
49.3% high complexity
0.0% medium
50.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$70,263
Total received (2018-2024)
Avg $10,038/year across 7 years
Top 8% in TX for cardiovascular disease
32
Companies
388
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$44,286 (63.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13,002 (18.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,975 (18.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$42,575
2023$2,682
2022$14,011
2021$979
2020$1,319
2019$4,240
2018$4,456
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$31,966
Boston Scientific Corporation
$24,897
Medical Device Business Services, Inc.
$4,800
BOSTON SCIENTIFIC CORPORATION
$1,538
Impulse Dynamics (USA) Inc.
$1,486
Philips North America LLC
$1,282
Philips Electronics North America Corporation
$1,181
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$621
SANOFI-AVENTIS U.S. LLC
$435
Medtronic, Inc.
$341
Janssen Pharmaceuticals, Inc
$332
Biosense Webster, Inc.
$288
PFIZER INC.
$231
iRhythm Technologies, Inc.
$127
Aziyo Biologics, Inc.
$102
CARDIVA MEDICAL, INC.
$99
E.R. Squibb & Sons, L.L.C.
$93
Invuity, Inc.
$70
Medtronic Vascular, Inc.
$48
ATRICURE, INC.
$44
Inari Medical, Inc.
$39
AtriCure, Inc.
$38
Baxter Healthcare
$34
Stereotaxis Inc
$27
AltaThera Pharmaceuticals LLC
$23
Chiesi USA, Inc.
$22
Alnylam Pharmaceuticals Inc.
$21
Lundbeck LLC
$20
Regeneron Healthcare Solutions, Inc.
$19
Amgen Inc.
$15
AstraZeneca Pharmaceuticals LP
$14
Bardy Diagnostics, Inc.
$10
Top 3 companies account for 87.8% of total payments
Associated products mentioned in payments ›
(9520) IGT Devices Undivided · ACCOLADE · AMPLATZER · AMPLATZER AMULET · ARCTIC FRONT ADVANCE · ATRICLIP LAA EXCLUSION SYSTEM · AVEIR · Assurity Pacemaker · Azure · BRILINTA · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · COBALT DR MRI SURESCAN · CONFIRM RX · CVX-300 · CapSure Sense · Cardiva VASCADE MVP VVCS 6-12F · Carnation Ambulatory Monitor · Carto 3 · Carto 3 System · Claria MRI · Cobalt · Confirm Rx · Corlanor · ECM · ECM Patch · ELIQUIS · EMBLEM · EMBLEM MRI S-ICD · EMBLEM SICD ELECTRODE DELIVERY SYSTEM · EPI-SENSE GUIDED COAGULATION SYS · FLOWTRIEVER CATHETER · GENERAL THERAPIES · GENERAL TACHY · GENERAL THERAPIES · GENERAL - TACHY · GENERAL - THERAPIES · GENERAL BRADY · GENERAL PAIN MANAGEMENT · GENERAL TACHY · GENERAL THERAPIES · General - Therapies · General - Vascular Access · HeartMate · Hillrom - Carnation Ambulatory Monitor · IGT_D FM · INGEVITY · JOT DX · KENGREAL · LATITUDE · LATITUDE Communicator Power Supply · LINQ II · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LUXDX · Lasers · LifeVest · MULTAQ · NA · NORTHERA · Niobe · ONPATTRO · OPTIMIZER · Optimizer · PERCLOSE PROSTYLE · PRALUENT · Perclose ProGlide suture mediated closure system · Photonblade · Pouch · RELIANCE 4 FRONT · RESONATE · RHYTHMIA · S · S-ICD · SQ-RX PULSE GENERATOR · Sotalol Hydrochloride · Soundstar · TactiCath Quartz CFA Catheter · VIGILANT · VYNDAQEL · Vascular Closure Device · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO Patch · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (63%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 8% for cardiovascular disease in TX.
Equivalent to $1,135 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
306
Per 100K population
11.8
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Dohadwala is a electrophysiology & remote specialist, with above-average Medicare volume (top 11% in TX), and high industry engagement (consulting-driven, top 8%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Dohadwala experienced with remote pacemaker/defibrillator monitoring, 90 days?
Based on Medicare claims data, Dr. Dohadwala performed 1,048 remote pacemaker/defibrillator monitoring, 90 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dohadwala receive payments from pharmaceutical companies?
Yes. Dr. Dohadwala received a total of $70,263 from 32 companies across 388 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dohadwala's costs compare to other cardiovascular diseases in Dallas?
Dr. Dohadwala's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dohadwala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Dallas
Browse cardiovascular diseases in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medical Device Business Services, Inc. Payments to Doctors
See all physicians who received payments from Medical Device Business Services, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology